29 October 2004
New Possibilities of The Therapeutic Intervention in Transplantation
M Magott - ProcelewskaAnn Transplant 2004; 9(3): 19-24 :: ID: 10211
Abstract
Immune tolerance of the graft would allow for long-term graft survival without immunosuppressive drugs. Experimental studies showed that both CD28/B7 and CD40L/CD40 costimulations are critical for allograft rejection and their blockade during transplantation induced a decrease of proliferation of alloreactive T cells and an increase of their death by apoptosis. Blocking B7 costimulation increased rodent allograft survival of kidney, liver and pancreatic islets but this is insufficient weapon in the induction of graft tolerance. The combination of the two treatments has synergistic effects. Additional CD40/CD40L blockade represents a adjunct strategy to prevent graft rejection and it has been reported to induce donor specific peripheral tolerance. This therapy prevented acute cardiac allograft rejection and it markedly prolonged allograft survival of kidney and islets in nonhuman primates. A loss of donor-specific alloreactivity has been demonstrated in these experimental models. Calcineurin inhibitors may antagonize the therapeutic effects of costimulatory blockade which may suggest that T cell receptor signaling may be required for tolerance induction.
Keywords: Costimulatory Pathways, Tolerance Induction, CD28/B7 Blockade, CTLA4Ig, Anti-CD40L Monoclonal Antibody;, Graft Survival
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860